Pharmaceutical Desonide Micronized Powder from Canada
Micronized Desonide powder optimized for topical formulation, meeting USP/NF standards as a corticosteroid hormone analogue. Falls under HTS 2937.29.10.00 due to specific listing and primary hormonal therapeutic use. Used in prescription-strength skin treatments for eczema and dermatitis.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include particle size distribution certificate; ensure ICH stability testing documentation; avoid retail packaging to maintain bulk chemical classification